The regulators have not revoked approval of Pfizer's vaccine, which was approved by the FDA in late 2020, even after Brook Jackson disclosed problems at sites managed by Ventavia Research Group. Now, Pfizer is asking to dismiss the lawsuit revealing problems at COVID-19 vaccine trial sites entirely.
Pfizer has requested a US court to dismiss a case filed by a whistleblower who exposed flaws at Pfizer's COVID-19 vaccine testing facility.
In a lawsuit disclosed in February, whistleblower Brook Jackson claimed that Pfizer and related parties breached clinical trial standards and federal statutes, including the False Claims Act.
Pfizer argued in its movement to dismiss that the regulations do not pertain to its vaccine deal with the US Department of Defense because it was signed under the department's Other Transaction Authority (OTA), which allows contract holders to avoid many of the rules and regulations that normally apply to contracts.
According to Pfizer, Jackson's a...